Skip to main
TVTX
TVTX logo

Travere Therapeutics (TVTX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Travere Therapeutics (TVTX) Stock

About Travere Therapeutics (TVTX)

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Market cap$1.29B
Today's volume1.59M
Revenue (TTM)$273.53M
Avg. daily volume1.79M
EBITDA (TTM)-$178.61M
Open$14.71
Price / earnings ratio-5.17x
Today's range$14.37 - $14.93
Debt / equity1220.07x
52 week range$6.8 - $25.29
5 year debt / equity378.98x
Beta (LTM)1.2x
Interest coverage-22.91x
Dividend & yield$0.00 (0.00%)
Current ratio2.05x
Ex-dividend date
Next earningsJul 31, 2025
Dividend payable date

Travere Therapeutics Stock Rating

What analysts recommend for TVTX stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 31%
Buy 56%
Hold 13%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for TVTX stock is $1.29B

The current P/E ratio for TVTX stock is -5.17

The 52-week high for TVTX stock is $25.29. The current TVTX stock price $undefined is 100.00% below its 52-week high

The 52-week low for TVTX stock is $6.80. The current TVTX stock price $undefined has increased 100.00% from its 52-week low

No, the TVTX stock does not pay dividends to its shareholders

The target price for TVTX stock is $33.62 based on the average of what a group of analyst think TVTX stock could be worth at a future date. This is not a prediction by Public.com

How to buy TVTX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in TVTX stock

    Navigate to the Explore page. Then, type TVTX into the search bar. When you see TVTX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased TVTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Travere Therapeutics Stock Earnings

The value each TVTX share was expected to gain vs. the value that each TVTX share actually gained.

Travere Therapeutics (TVTX) reported Q1 2025 earnings per share (EPS) of -$0.19, beating estimates of -$0.39 by 51.28%. In the same quarter last year, Travere Therapeutics's earnings per share (EPS) was -$1.51. Travere Therapeutics is expected to release next earnings on 07/31/2025, with an earnings per share (EPS) estimate of $0.

Buy Travere Therapeutics (TVTX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.